This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Conjunctivitis, Allergic
and you are
over 10
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

This study will evaluate the efficacy of Lastacaft® (Alcaftadine 0.25%) and Pataday™ (Olopatadine 0.2%) as compared to each other and to placebo in the prevention of ocular itching associated with allergic conjunctivitis.

Provided treatments

  • Drug: Alcaftadine 0.25%
  • Drug: Olopatadine 0.2%
  • Drug: dextran 70 0.1%/hydroxypropyl methylcellulose 0.3%

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01732757. The sponsor of the trial is Allergan and it is looking for 157 volunteers for the current phase.
Official trial title: